Global IVD Companies Issue Third Quarter 2024 Earnings

By Robert Michel | From the Volume XXXI, No. 16 – November 25, 2024 Issue

HERE IS A SUMMARY OF THE SECOND QUARTER FINANCIAL PERFORMANCE of …

Read More

---

Global IVD Companies Report Second Quarter 2024 Earnings

By Robert Michel | From the Volume XXXI, No. 13 – September 23, 2024 Issue

IN THE SECOND QUARTER OF 2024, in vitro diagnostics (IVD) companies reported solid revenues as well as new tests, analyzers, and automation. Most of the IVD companies boosted diagnostic sales in low single digit amounts. During the earnings calls, financial analysts asked company leade…

Read More

---

Global IVD Companies Report First Quarter 2024 Earnings

By Robert Michel | From the Volume XXXI, No. 9 – July 1, 2024 Issue

IN THEIR INITIAL FINANCIAL REPORTING F…

Read More

---

Significant Developments Are Shaping Lab Market

By Robert Michel | From the Volume XXXI, No. 7 – May 20, 2024 Issue

CEO SUMMARY: With 140 speakers and 1,000+ attendees, this year’s Executive War College again provided a comprehensive picture of the specific forces reshaping the U.S. market for lab testing services. Presented here is a smorgasbord of information and innovation shared by different spea…

Read More

---

Most IVD Firms Increase Q3 2023 Base Business Revenue

By Robert Michel | From the Volume XXX, Number 17 – December 4, 2023 Issue

Most in vitro diagnostics (IVD) companies reported increases in base business during the third quarter (Q3) 2023. The numbers, in the single digits, softened the blow from the continuing drop-off in COVID-19 test sales. Manufacturers of tests and laboratory instruments are launching ne…

Read More

---

IVD Companies Launch New Assays, Analyzers, Automation

By Donna Marie Pocius | From the Volume XXX, No. 12 – August 21, 2023 Issue

Steep declines in SARS-CoV-2 test revenue were reported by the top in vitro diagnostics (IVD) companies in Q2 2023 earnings compared to a year earli…

Read More

---

2022 Ranking of the World’s Top 12 IVD Corporations

By Scott Wallask | From the Volume XXX, No. 11 – July 31, 2023 Issue

WHILE THE TOP FOUR IN VITRO DIAGNOSTICS (IVD) MANUFACTURERS kept their collective hold on the market compared to 2021, the big surprise was that Thermo Fisher Scientific’s…

Read More

---

Despite COVID-19 Losses, IVD Executives Remain Upbeat

By Donna Marie Pocius | From the Volume XXX, No. 8 – May 30, 2023 Issue

Continuing declines in COVID-19 test revenues was a common theme during the first quarte…

Read More

---

Public IVD Companies Report Q4, Full-Year 2022 Earnings

By Robert Michel | From the Volume XXX No. 3 – February 13, 2023 Issue

YEAR-END AND Q4 EARNINGS REPORTS FROM MAJOR IN VITRO DIAGNOSTICS (IVD) COMPANIES pointed to a welcome sign of core diagnostic business rebounding.  That’s the good news for IVD firms. The bad news? All of the SARS-CoV-2 testing revenue that th…

Read More

---

Top Public IVD Companies Report Q3/Q4 2022 Earnings

By Robert Michel | From the Volume XXIX, No. 17 – December 12, 2022 Issue

IT WAS A MIXED BAG OF THIRD QUARTER FINANCIAL RESULTS for the nation’s largest in vitro diagnostics (IVD) manufacturers, with COVID-19 testing volume a contributing factor.  Fluctuating demand for SARS-CoV-2 testing proved perplexing, as some IV…

Read More

---